136 related articles for article (PubMed ID: 29164814)
21. Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis.
Borbély É; Botz B; Bölcskei K; Kenyér T; Kereskai L; Kiss T; Szolcsányi J; Pintér E; Csepregi JZ; Mócsai A; Helyes Z
Brain Behav Immun; 2015 Mar; 45():50-9. PubMed ID: 25524130
[TBL] [Abstract][Full Text] [Related]
22. Arthritis imaging using a near-infrared fluorescence folate-targeted probe.
Chen WT; Mahmood U; Weissleder R; Tung CH
Arthritis Res Ther; 2005; 7(2):R310-7. PubMed ID: 15743478
[TBL] [Abstract][Full Text] [Related]
23. Studying Chemokine Control of Neutrophil Migration In Vivo in a Murine Model of Inflammatory Arthritis.
Miyabe Y; Kim ND; Miyabe C; Luster AD
Methods Enzymol; 2016; 570():207-31. PubMed ID: 26921948
[TBL] [Abstract][Full Text] [Related]
24. K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis.
Christensen AD; Haase C; Cook AD; Hamilton JA
Front Immunol; 2016; 7():213. PubMed ID: 27313578
[TBL] [Abstract][Full Text] [Related]
25. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
[TBL] [Abstract][Full Text] [Related]
26. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
[TBL] [Abstract][Full Text] [Related]
27. Hyperleptinemia suppresses aggravation of arthritis of collagen-antibody-induced arthritis in mice.
Okano T; Koike T; Tada M; Sugioka Y; Mamoto K; Inui K; Okihana H; Ebihara K; Nakao K; Nakamura H
J Orthop Sci; 2015 Nov; 20(6):1106-13. PubMed ID: 26293802
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis.
Nehmar R; Alsaleh G; Voisin B; Flacher V; Mariotte A; Saferding V; Puchner A; Niederreiter B; Vandamme T; Schabbauer G; Kastner P; Chan S; Kirstetter P; Holcmann M; Mueller C; Sibilia J; Bahram S; Blüml S; Georgel P
Arthritis Rheumatol; 2017 Nov; 69(11):2124-2135. PubMed ID: 28777892
[TBL] [Abstract][Full Text] [Related]
29. IL-12p35 promotes antibody-induced joint inflammation by activating NKT cells and suppressing TGF-beta.
Park Y; Kim HS; Ahn JY; Yun D; Cho ML; Hong S; Kim HY; Chung DH
J Immunol; 2010 Aug; 185(3):1476-84. PubMed ID: 20581146
[TBL] [Abstract][Full Text] [Related]
30. In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET.
Fuchs K; Kohlhofer U; Quintanilla-Martinez L; Lamparter D; Kötter I; Reischl G; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2013 Jan; 54(1):151-8. PubMed ID: 23213198
[TBL] [Abstract][Full Text] [Related]
31. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
[TBL] [Abstract][Full Text] [Related]
32. The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.
Wong MX; Hayball JD; Hogarth PM; Jackson DE
J Clin Immunol; 2005 Jan; 25(1):19-28. PubMed ID: 15742154
[TBL] [Abstract][Full Text] [Related]
33. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
[TBL] [Abstract][Full Text] [Related]
34. Cutting Edge: The murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis.
Mancardi DA; Jönsson F; Iannascoli B; Khun H; Van Rooijen N; Huerre M; Daëron M; Bruhns P
J Immunol; 2011 Feb; 186(4):1899-903. PubMed ID: 21248252
[TBL] [Abstract][Full Text] [Related]
35. Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model.
Jang E; Kim HR; Cho SH; Paik DJ; Kim JM; Lee SK; Youn J
Arthritis Rheum; 2006 Feb; 54(2):492-8. PubMed ID: 16447223
[TBL] [Abstract][Full Text] [Related]
36. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
37. HIF-2α-induced chemokines stimulate motility of fibroblast-like synoviocytes and chondrocytes into the cartilage-pannus interface in experimental rheumatoid arthritis mouse models.
Huh YH; Lee G; Lee KB; Koh JT; Chun JS; Ryu JH
Arthritis Res Ther; 2015 Oct; 17():302. PubMed ID: 26510617
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease.
Maicas N; Ferrándiz ML; Brines R; Ibáñez L; Cuadrado A; Koenders MI; van den Berg WB; Alcaraz MJ
Antioxid Redox Signal; 2011 Aug; 15(4):889-901. PubMed ID: 21406003
[TBL] [Abstract][Full Text] [Related]
39. Common mechanisms in immune-mediated inflammatory disease.
Firestein GS; Corr M
J Rheumatol Suppl; 2005 Feb; 73():8-13; discussion 29-30. PubMed ID: 15693110
[TBL] [Abstract][Full Text] [Related]
40. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
Odobasic D; Yang Y; Muljadi RC; O'Sullivan KM; Kao W; Smith M; Morand EF; Holdsworth SR
Arthritis Rheumatol; 2014 Apr; 66(4):907-17. PubMed ID: 24757143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
